1. From the Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts;
2. the Department of Ophthalmology, University of California, Irvine, Orange, California; and
3. ReNeuron Group, Guildford, Surrey, United Kingdom.